In a Second Suit, Lupin Atlantis Holdings Sues Apotex and Ethypharm

  • March 23, 2011

Lupin Atlantis Holdings filed suit against Apotex and Ethypharm over two patents related to pharmaceutical compositions comprising micronized fenofibrate to treat patient conditions of hypertriglyceridemia and/or hypercholesterolemia and/or hyperlipidemia. 3/18, District of Delaware, 1:2011cv00234


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×